• Explore /
  • Poster
  • / Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC).

Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC).

Abstract Poster

Authors

null

Giulia Pasello

Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy

Giulia Pasello , Aline Sueli Coelho Fabricio , Paola Del Bianco , Adolfo Favaretto , Valentina Salizzato , Luisa Piccin , Fable Zustovich , Costanza De Rossi , Jacopo Pigozzo , Alessio Fabozzi , Beatrice Benetti , Laura Tiozzo Fasiolo , Laura Bonanno , Valentina Guarneri , Gian Luca De Salvo , Dario Palleschi , Massimo Gion , Vanna Chiarion-Sileni

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Circulating Biomarkers

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 2549)

DOI

10.1200/JCO.2022.40.16_suppl.2549

Abstract #

2549

Poster Bd #

204

Abstract Disclosures

Similar Posters

Poster

2017 ASCO-SITC Clinical Immuno-Oncology Symposium

Single-cell cytokine profiling of tumor-infiltrating T cells to measure patient responses to anti-PD-1 therapy.

Single-cell cytokine profiling of tumor-infiltrating T cells to measure patient responses to anti-PD-1 therapy.

First Author: Sean Mackay

First Author: Rongsu Qi

First Author: Nicola Maurea

First Author: Banani Majumdar